Company secures 7th position nationwide in India's Great Mid-size Workplaces 2026, reinforcing its people-first culture as it marks 75 years of excellence
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing
National conference brings together 160+ experts from six states to advance blood quality and safety standards
The resolution significantly reduces a long-standing contingent liability from the company's books
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
His expertise spans supply chain management, strategic planning, operational transformation, and cross-functional leadership
Innovative start-up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
Subscribe To Our Newsletter & Stay Updated
